Clinical Trial Update: REported Outcomes in COPD With Trixeo in Real worlD

View source ↗

Summary

A completed real-world study by AstraZeneca evaluating outcomes of using Trixeo in chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trixeo

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED